METTL3 was found to increase the sensitivity of cells to anticancer reagents such as gemcitabine, 5‐fluorouracil, cisplatin and irradiation in pancreatic cancer, indicating the potential role of METTL3 in chemo‐ and radiotherapy resistance.72 Here, METTL3 is linked to pancreatic neoplasm.